Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
130,883
-
Shares change
-
+13,154
-
Total reported value, excl. options
-
$484,000
-
Value change
-
+$46,115
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$3.68
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q3 2019
10 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q3 2019.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130,883 shares
of 66,587,586 outstanding shares and own 0.2% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (75,654 shares), STIFEL FINANCIAL CORP (22,599 shares), VANGUARD GROUP INC (15,150 shares), BlackRock Inc. (10,659 shares), BANK OF MONTREAL /CAN/ (2,444 shares), MORGAN STANLEY (2,227 shares), BANK OF AMERICA CORP /DE/ (1,007 shares), UBS Group AG (572 shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (571 shares), and PANAGORA ASSET MANAGEMENT INC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.